Pharmaceutical chief / former CEO of Turing Pharmaceuticals Martin Shkreli has arrived at a house hearing with U.S. senate on price hikes for a drug sold by a company that he acquired. Shkreli, in the video below refused to answer questions in his appearance Thursday before the House Oversight and Government Reform Committee.
Shkreli, widely scorned for hiking the price of a long-established and potentially lifesaving drug by more than 5,000 percent, has said he’s exercising his Fifth Amendment right against self-incrimination.
The 32-year-old Shkreli faces separate criminal charges of securities fraud related to another drug company. Also going before lawmakers is the interim CEO of Canada’s largest drugmaker, Valeant Pharmaceuticals. Both companies have sharply raised prices for drugs taken by patients with heart problems, AIDS, cancer and other conditions. (AP)